For research use only. Not for human consumption. Nothing on this page describes or implies any human use, therapeutic effect, or health outcome. All mechanisms are described at the in-vitro, cellular, or animal-research-model level only.
A curated selection of the research compounds in the Vantage Aminos catalog most studied within energy-metabolism and metabolic-pathway research models. Each is a distinct chemical entity acting on a different node of cellular and systemic metabolism, from mitochondrial signaling to enzyme inhibition to growth-hormone-axis and central-nervous-system pathways.
Every item is American-made and U.S. synthesized. Where a lot has been tested, its batch Certificate of Analysis is published on that product's own page. These materials are supplied strictly for laboratory research.
What links these compounds
These compounds share a research domain: they appear in the preclinical literature on cellular and systemic energy metabolism. They do not share an effect or an application. Each acts through a different mechanism and is studied independently.
CompoundClassResearch-model mechanismCAS
TesamorelinStabilized GHRH(1-44) analog peptideGHRH-receptor agonism / growth-hormone-axis signaling research models218949-48-5
NAD+Redox cofactor (not a peptide)NAD+/NADH redox cycling, sirtuin and PARP enzyme research models53-84-9
MOTS-cMitochondrial-derived peptideMitochondrial-signaling and cellular-metabolism research models1627580-64-6
AOD-9604Modified hGH(176-191) fragment peptideAdipose-tissue and lipid-metabolism research models221231-10-3
SLU-PP-332Small-molecule ERR pan-agonistEstrogen-related-receptor (ERRα/β/γ) and oxidative-metabolism research models303760-60-3
5-Amino-1MQSmall-molecule NNMT inhibitor (not a peptide)NNMT enzyme-inhibition / nicotinamide-metabolism research models42464-96-0
TesofensineSmall-molecule monoamine reuptake inhibitorCNS monoamine-transporter (NET/DAT/SERT) research models402856-42-2